1. Icariside II prevents high‐glucose‐induced injury on human cavernous endothelial cells through Akt‐eNOS signaling pathway
   H. Li et al, 2015, Andrology CrossRef
2. Icariside II inhibits the EMT of NSCLC cells in inflammatory microenvironment via down-regulation of Akt/NF-κB signaling pathway
   Jie Song et al, 2017, Molecular Carcinogenesis CrossRef
3. Combined Treatment with JFKD and Gefitinib Overcomes Drug Resistance in Non-Small Cell Lung Cancer
   Xiaoming Huang et al, 2021, Current Pharmaceutical Biotechnology CrossRef
4. Baohuoside I Suppresses Invasion of Cervical and Breast Cancer Cells through the Downregulation of CXCR4 Chemokine Receptor Expression
   Buyun Kim et al, 2014, Biochemistry CrossRef
5. Components from the Traditional Chinese Medicine Acts as Protein Kinase Inhibitors
   Minghua Liu et al, 2017, Molecular Oncology: Underlying Mechanisms and Translational Advancements CrossRef
6. Efficient production of isoquercitin, icariin and icariside II by a novel thermostable α-l-rhamnosidase PodoRha from Paenibacillus odorifer with high α-1, 6-/α-1, 2- glycoside specificity
   Jingcong Xie et al, 2022, Enzyme and Microbial Technology CrossRef
7. Development of Certain Protein Kinase Inhibitors with the Components from Traditional Chinese Medicine
   Minghua Liu et al, 2017, Frontiers in Pharmacology CrossRef
8. Blockade of epidermal growth factor receptor/mammalian target of rapamycin pathway by Icariside II results in reduced cell proliferation of osteosarcoma cells
   Ya-di Geng et al, 2014, Food and Chemical Toxicology CrossRef
9. Combined Treatment withEpimedium koreanumNakai Extract and Gefitinib Overcomes Drug Resistance Caused by T790M Mutation in Non-Small Cell Lung Cancer Cells
   Jie Song et al, 2014, Nutrition and Cancer CrossRef
10. Structural Optimization of Marine Natural Product Pretrichodermamide B for the Treatment of Colon Cancer by Targeting the JAK/STAT3 Signaling Pathway
    Yue Zhou et al, 2024, Journal of Medicinal Chemistry CrossRef
11. The Anticancer Properties of Herba Epimedii and Its Main Bioactive Componentsicariin and Icariside II
    Meixia Chen et al, 2016, Nutrients CrossRef
12. Inhibiting STAT3 signaling pathway by natural products for cancer prevention and therapy: In vitro and in vivo activity and mechanisms of action
    Jing Yang et al, 2022, Pharmacological Research CrossRef
13. Shikonin causes cell-cycle arrest and induces apoptosis by regulating the EGFR–NF-κB signalling pathway in human epidermoid carcinoma A431 cells
    Rong Tian et al, 2015, Bioscience Reports CrossRef
14. Anti-Cancer Properties of the Naturally Occurring Aphrodisiacs: Icariin and Its Derivatives
    Hui-Li Tan et al, 2016, Frontiers in Pharmacology CrossRef
15. Polyphenolic molecules targeting STAT3 pathway for the treatment of cancer
    Md. Abdul Aziz et al, 2021, Life Sciences CrossRef
16. Characterization of a novel thermostable glucose-tolerant GH1 β-glucosidase from the hyperthermophile Ignisphaera aggregans and its application in the efficient production of baohuoside I from icariin and total epimedium flavonoids
    Jingcong Xie et al, 2020, Bioorganic Chemistry CrossRef
17. Pharmacology and Clinical Application of Plants in Epimedium L.
    Jun Jiang et al, 2016, Chinese Herbal Medicines CrossRef
18. Icariside II: Anticancer Potential and Molecular Targets in Solid Cancers
    Fei Xu et al, 2021, Frontiers in Pharmacology CrossRef
19. Therapeutic effects of icariin and icariside II on diabetes mellitus and its complications
    Wei Jiang et al, 2024, Critical Reviews in Food Science and Nutrition CrossRef
20. Skin cancer and new treatment perspectives: A review
    M.C.F. Simões et al, 2015, Cancer Letters CrossRef
21. The Anti-tumor Function of Shikonin by Targeting EGFR/AKT/mTOR Signaling in Human Osteosarcoma Cells
    Rui-Dan Zhu et al, 2024, Pharmacognosy Magazine CrossRef
22. Icariside II potentiates the anti-PD-1 antitumor effect by reducing chemotactic infiltration of myeloid-derived suppressor cells into the tumor microenvironment via ROS-mediated inactivation of the SRC/ERK/STAT3 signaling pathways
    Qing Kong et al, 2023, Phytomedicine CrossRef
23. Icariin as a potential anticancer agent: a review of its biological effects on various cancers
    Fang-Yuan Liu et al, 2023, Frontiers in Pharmacology CrossRef
24. Icarisid II inhibits the proliferation of human osteosarcoma cells by inducing apoptosis and cell cycle arrest
    Yuanyuan Tang et al, 2017, Tumor Biology CrossRef
25. Targeting epidermal growth factor receptors and downstream signaling pathways in cancer by phytochemicals
    Onat Kadioglu et al, 2015, Targeted Oncology CrossRef